Shareholdings
Concept |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
As at 2023-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shareholdings | ||||||||||||||||||
Reporting company | ||||||||||||||||||
Details of specified investment shares held for purposes other than pure investment | ||||||||||||||||||
Issue |
㈱みずほフィナンシャルグループ
|
テイカ㈱
|
日産化学㈱
|
㈱紀陽銀行
|
㈱池田泉州ホールディングス
|
㈱島精機製作所
|
㈱三菱UFJフィナンシャル・グループ
|
花王㈱
|
㈱マナック・ケミカル・パートナーズ
|
— | — | — | — | — | — | — | — | — |
Number of shares |
8,310
xbrli:shares
|
180,665
xbrli:shares
|
186,000
xbrli:shares
|
212,612
xbrli:shares
|
45,949
xbrli:shares
|
2,050
xbrli:shares
|
560
xbrli:shares
|
10,250
xbrli:shares
|
120,000
xbrli:shares
|
105,000
xbrli:shares
|
8,310
xbrli:shares
|
45,949
xbrli:shares
|
186,000
xbrli:shares
|
10,250
xbrli:shares
|
2,050
xbrli:shares
|
180,631
xbrli:shares
|
212,612
xbrli:shares
|
560
xbrli:shares
|
Carrying amount |
25,312,000
JPY
|
274,792,000
JPY
|
1,064,850,000
JPY
|
393,757,000
JPY
|
18,149,000
JPY
|
2,851,000
JPY
|
871,000
JPY
|
57,789,000
JPY
|
74,400,000
JPY
|
84,315,000
JPY
|
15,606,000
JPY
|
10,660,000
JPY
|
1,114,140,000
JPY
|
52,961,000
JPY
|
3,860,000
JPY
|
212,061,000
JPY
|
315,516,000
JPY
|
474,000
JPY
|
Purpose of shareholding, overview of business alliance, quantitative effects of shareholding and reason for increase in number of shares |
主に資金調達先として、円滑な金融取引の維持
|
原料仕入先として、営業取引関係の維持・強化 取引先持株会を通じた株式の取得による増加
|
農薬用中間物等の販売先として、営業取引関係の維持・強化
|
主に資金調達先として、円滑な金融取引の維持
|
主に資金調達先として、円滑な金融取引の維持
|
地域経済の連携
|
主に資金調達先として、円滑な金融取引の維持
|
界面活性剤の販売先として、営業取引関係の維持・強化
|
原料仕入先として、営業取引関係の維持・強化
|
— | — | — | — | — | — | — | — | — |
Whether issuer of aforementioned shares holds reporting company's shares |
無
|
有
|
有
|
有
|
無
|
有
|
有
|
無
|
有
|
— | — | — | — | — | — | — | — | — |